142 related articles for article (PubMed ID: 8723459)
1. In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model.
Bugnon D; Potel G; Xiong YQ; Caillon J; Kergueris MF; Le Conte P; Baron D; Drugeon H
Antimicrob Agents Chemother; 1996 May; 40(5):1164-9. PubMed ID: 8723459
[TBL] [Abstract][Full Text] [Related]
2. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
Potel G; Caillon J; Fantin B; Raza J; Le Gallou F; Lepage JY; Le Conte P; Bugnon D; Baron D; Drugeon H
Antimicrob Agents Chemother; 1991 Jan; 35(1):111-6. PubMed ID: 2014965
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model.
Robaux MA; Dube L; Caillon J; Bugnon D; Kergueris MF; Navas D; Le Conte P; Baron D; Potel G
J Antimicrob Chemother; 2001 May; 47(5):617-22. PubMed ID: 11328773
[TBL] [Abstract][Full Text] [Related]
4. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
Xiong YQ; Caillon J; Kergueris MF; Drugeon H; Baron D; Potel G; Bayer AS
Antimicrob Agents Chemother; 1997 Apr; 41(4):823-6. PubMed ID: 9087497
[TBL] [Abstract][Full Text] [Related]
5. In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.
Juvin ME; Potel G; Caillon J; Xiong YQ; Bugnon D; Le Conte P; Baron DI; Drugeon HB
Antimicrob Agents Chemother; 1994 Apr; 38(4):883-5. PubMed ID: 8031065
[TBL] [Abstract][Full Text] [Related]
6. Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.
Potel G; Caillon J; Le Gallou F; Bugnon D; Le Conte P; Raza J; Lepage JY; Baron D; Drugeon H
Antimicrob Agents Chemother; 1992 Apr; 36(4):744-50. PubMed ID: 1503436
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection.
Blaser J
J Antimicrob Chemother; 1991 May; 27 Suppl C():21-8. PubMed ID: 1906863
[TBL] [Abstract][Full Text] [Related]
8. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
[TBL] [Abstract][Full Text] [Related]
9. Intravegetation antimicrobial distribution in aortic endocarditis analyzed by computer-generated model. Implications for treatment.
Bayer AS; Crowell D; Nast CC; Norman DC; Borrelli RL
Chest; 1990 Mar; 97(3):611-7. PubMed ID: 2106410
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of continuous-infusion meropenem for the treatment of Serratia marcescens ventriculitis in a pediatric patient.
Cies JJ; Moore WS; Calaman S; Brown M; Narayan P; Parker J; Chopra A
Pharmacotherapy; 2015 Apr; 35(4):e32-6. PubMed ID: 25884534
[TBL] [Abstract][Full Text] [Related]
11. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity.
Garraffo R; Drugeon HB; Dellamonica P; Bernard E; Lapalus P
Antimicrob Agents Chemother; 1990 Apr; 34(4):614-21. PubMed ID: 2111658
[TBL] [Abstract][Full Text] [Related]
12. [Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation].
Potel G; Caillon J; Xiong YQ; Bugnon D; Conte PL; Drugeon HB; Baron D
Presse Med; 1995 Apr; 24(16):750-2. PubMed ID: 7784412
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
[TBL] [Abstract][Full Text] [Related]
14. Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
McClure JT; Rosin E
Am J Vet Res; 1998 Jun; 59(6):750-5. PubMed ID: 9622746
[TBL] [Abstract][Full Text] [Related]
15. Serratia marcescens prosthesis infection successfully treated with meropenem after imipenem failure.
Lefort A; Righi S; Jauréguy F; Bégué T; Robineau M; Bouchaud O; Lortholary O
J Infect; 2005 Aug; 51(2):E45-7. PubMed ID: 16038749
[TBL] [Abstract][Full Text] [Related]
16. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma.
Körner RJ; Nicol A; Reeves DS; MacGowan AP; Hows J
J Infect; 1994 Jul; 29(1):73-6. PubMed ID: 7963638
[TBL] [Abstract][Full Text] [Related]
19. [Aminoglycoside determinations calculated in endocarditis vegetations. Relations with clinical practices during infectious endocarditis treatment with amikacin].
Confesson MA; Barbaut X; Maire P; Vergnaud JM; el Brouzi A; Jelliffe RW
Therapie; 1994; 49(1):27-34. PubMed ID: 8091362
[TBL] [Abstract][Full Text] [Related]
20. Aspirin treatment for neonatal infectious endocarditis.
Adler A; Litmanovitz I; Bauer S; Dolfin T
Pediatr Cardiol; 2004; 25(5):562-4. PubMed ID: 15534725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
